{"schema_version":"alpha-profile-public-v1","slug":"j-kelly-ganjei","canonical_url":"https://registry.alpha.ac/people/j-kelly-ganjei","as_of":"2026-09-18T00:41:28.978001+00:00","published_at":"2026-09-02T02:37:24.00596+00:00","last_reviewed_at":"2026-05-16T04:00:03.585+00:00","identity":{"display_name":"J. Kelly Ganjei","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Inmune Bio, Inc.","company_slug":"inmune-bio-inc","exchange":"NASDAQ","ticker":"INMB","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2016-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T23:28:01.101+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=j-kelly-ganjei","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=j-kelly-ganjei&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Former CEO and President of AmplifyBio LLC and former CEO and Chairman of Cognate BioServices (acquired by Charles River Laboratories). Nearly 30 years of experience in life science, venture capital and IT sectors, including developing global informatics infrastructure at TissueGene."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Inmune Bio, Inc.","organizationId":"inmune-bio-inc","title":"Director","period":"2016-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Inmune Bio, Inc.","company_slug":"inmune-bio-inc","exchange":"NASDAQ","ticker":"INMB","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2016-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","effective_date":"2026-04-23","last_checked_at":"2026-04-24T23:28:01.101+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for J. Kelly Ganjei as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:27:05.160904+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T00:27:05.020613+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"ai_ml_experience","claim_value":true,"claim_text":"Executive extraction classified AI/ML experience for J. Kelly Ganjei as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T04:00:03.799521+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T04:00:03.655545+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"J. Kelly Ganjei currently serves as Chair at Inmune Bio, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:27:05.126206+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T00:27:05.020613+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Nominating/Governance"],"claim_text":"J. Kelly Ganjei serves on Compensation, Nominating/Governance.","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:27:05.144669+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T00:27:05.020613+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for J. Kelly Ganjei as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:27:05.193107+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T00:27:05.020613+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Executive extraction classified cybersecurity experience for J. Kelly Ganjei as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T04:00:03.838524+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T04:00:03.655545+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_company","claim_value":"Inmune Bio, Inc.","claim_text":"J. Kelly Ganjei is associated with Inmune Bio, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T04:00:03.782193+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T04:00:03.655545+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"executive_title","claim_value":"Independent Director","claim_text":"J. Kelly Ganjei is listed as Independent Director at Inmune Bio, Inc..","claim_state":"verified","valid_from":"2026-04-23","valid_to":null,"confidence":0.94,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T04:00:03.764112+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T04:00:03.655545+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Proxy extraction classified technology background for J. Kelly Ganjei as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T00:27:05.177476+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T00:27:05.020613+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":true,"claim_text":"Executive extraction classified technology background for J. Kelly Ganjei as true.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-16T04:00:03.81886+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"INMB DEF 14A executive officers","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","published_at":"2026-04-23T00:00:00+00:00","last_checked_at":"2026-05-16T04:00:03.655545+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:j-kelly-ganjei","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2016-01-01 · current","organization":"Inmune Bio, Inc.","organization_id":"inmune-bio-inc"},"claim_text":"Director at Inmune Bio, Inc. (2016-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/j-kelly-ganjei#profile","url":"https://registry.alpha.ac/people/j-kelly-ganjei","dateModified":"2026-05-16T04:00:03.585+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/j-kelly-ganjei#person","name":"J. Kelly Ganjei","url":"https://registry.alpha.ac/people/j-kelly-ganjei","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Inmune Bio, Inc.","tickerSymbol":"NASDAQ: INMB"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2016-01-01","memberOf":{"@type":"Organization","name":"Inmune Bio, Inc.","url":"https://registry.alpha.ac/companies/inmune-bio-inc","tickerSymbol":"NASDAQ: INMB"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1711754/000121390026047080/ea0286340-01.htm","name":"INMB DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/j-kelly-ganjei"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":8,"corroborated":2,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":10,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":1,"conflicts":[{"claim_type":"ai_ml_experience","kind":"extraction_disagreement","headline":false,"review_route":"internal_review","values":["false","true"],"publishers":["SEC EDGAR"],"source_types":["sec_filing"],"rationale":"Pipeline extraction runs disagree over documents from one publisher; routed to internal review, not headlined."}],"conflict_count":1,"headline_conflict_count":0,"internal_review_conflict_count":1,"contradiction_types":["ai_ml_experience"],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":8,"corroborated":2,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":10,"corroborated_claims":2,"sources":4,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-16T04:00:03.585+00:00","observed_at":"2026-09-18T00:41:28.978001+00:00","freshness_days":125}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"j-kelly-ganjei","canonical_url":"https://registry.alpha.ac/people/j-kelly-ganjei"},"publication":{"published_at":"2026-09-02T02:37:24.00596+00:00","last_reviewed_at":"2026-05-16T04:00:03.585+00:00","as_of":"2026-09-18T00:41:28.978001+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/j-kelly-ganjei","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/j-kelly-ganjei","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/j-kelly-ganjei.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}